Table 1.
Demographics of 101 patients with COVID-19
| All patients（n = 134） | Survivors (n = 33) | Non-survivors (n = 101) | P value | |
|---|---|---|---|---|
| Age, years | ||||
| Mean (s.d.) | 60.78 (12.98) | 46.45 (11.09) | 65.46 (9.74) | 0.00 |
| Range | 24–83 | 26–79 | 24–83 | |
| ≤44 | 19 (14.18%) | 16 (48.48%) | 3 (3.00%) | |
| 45–59 | 24 (25.37%) | 15 (45.45%) | 19 (18.80%) | |
| 60–74 | 61 (45.52%) | 1 (3.03%) | 60 (59.40%) | |
| ≥75 | 20 (14.93%) | 1 (3.03%) | 19 (18.80%) | |
| Sex | ||||
| Female | 47 (35.07%) | 10 (30.30%) | 37 (37.00%) | 0.51 |
| Male | 87 (64.93%) | 23 (69.70%) | 64 (64.00%) | |
| Days from onset to admission | 10.00 (8.00–13.00) | 9.50 (7–10.25) | 11.00 (8.00–13.50) | 0.06 |
| Blood group | ||||
| A | 57 (43.85%) | 13 (41.94%) | 44 (44.44%) | 0.45 |
| B | 35 (26.92%) | 6 (19.35%) | 29 (29.29%) | |
| AB | 13 (10%) | 5 (16.13%) | 8 (8.08%) | |
| O | 25 (19.23%) | 7 (22.58%) | 18 (18.18%) | |
| Chronic medical illness | ||||
| Cardiovascular and cerebrovascular disease | 53 (39.55%) | 4 (12.12%) | 49 (48.51%) | 0.00 |
| Endocrine system disease | 26 (19.40%) | 3 (9.09%) | 23 (22.77%) | 0.13 |
Values are median (IQR) or n/N (%), where N is the total number of patients with available data. P values comparing survivors and non-survivors are from t-test, χ2 test or Mann–Whitney U test. COVID-19 = coronavirus disease 2019.